1. Home
  2. CCNE vs TBPH Comparison

CCNE vs TBPH Comparison

Compare CCNE & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCNE
  • TBPH
  • Stock Information
  • Founded
  • CCNE 1865
  • TBPH 2013
  • Country
  • CCNE United States
  • TBPH United States
  • Employees
  • CCNE N/A
  • TBPH N/A
  • Industry
  • CCNE Major Banks
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCNE Finance
  • TBPH Health Care
  • Exchange
  • CCNE Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • CCNE 470.1M
  • TBPH 464.5M
  • IPO Year
  • CCNE N/A
  • TBPH N/A
  • Fundamental
  • Price
  • CCNE $21.89
  • TBPH $10.63
  • Analyst Decision
  • CCNE Hold
  • TBPH Buy
  • Analyst Count
  • CCNE 1
  • TBPH 4
  • Target Price
  • CCNE $25.00
  • TBPH $14.50
  • AVG Volume (30 Days)
  • CCNE 61.2K
  • TBPH 319.2K
  • Earning Date
  • CCNE 07-17-2025
  • TBPH 08-04-2025
  • Dividend Yield
  • CCNE 3.29%
  • TBPH N/A
  • EPS Growth
  • CCNE N/A
  • TBPH N/A
  • EPS
  • CCNE 2.34
  • TBPH N/A
  • Revenue
  • CCNE $219,886,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • CCNE $17.91
  • TBPH $43.53
  • Revenue Next Year
  • CCNE $27.71
  • TBPH N/A
  • P/E Ratio
  • CCNE $9.36
  • TBPH N/A
  • Revenue Growth
  • CCNE 1.97
  • TBPH 6.11
  • 52 Week Low
  • CCNE $18.82
  • TBPH $7.44
  • 52 Week High
  • CCNE $29.29
  • TBPH $11.82
  • Technical
  • Relative Strength Index (RSI)
  • CCNE 48.63
  • TBPH 57.46
  • Support Level
  • CCNE $21.43
  • TBPH $10.42
  • Resistance Level
  • CCNE $23.01
  • TBPH $11.00
  • Average True Range (ATR)
  • CCNE 0.53
  • TBPH 0.42
  • MACD
  • CCNE -0.00
  • TBPH -0.03
  • Stochastic Oscillator
  • CCNE 38.46
  • TBPH 35.50

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: